NARAE NANOTECH CORPORATION

As of June 30, 2026, NARAE NANOTECH CORPORATION carries a market capitalization of 64.14B, placing it among publicly traded companies globally. Its enterprise value stands at 9.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

NARAE NANOTECH CORPORATION's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, NARAE NANOTECH CORPORATION has 11.06M shares outstanding.

As of June 30, 2026, NARAE NANOTECH CORPORATION trades at a trailing price-to-earnings ratio of 0.98. The price-to-sales ratio is 1.00, and the price-to-book ratio stands at 0.49.

As of June 30, 2026, NARAE NANOTECH CORPORATION trades at an EV/EBITDA multiple of 3.15 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.16 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 3.15 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. NARAE NANOTECH CORPORATION trades at an EV/FCF ratio of 0.77, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 9.96B versus a market cap of 64.14B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, NARAE NANOTECH CORPORATION maintains a current ratio of 4.84, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.11, indicating conservative leverage, while an interest coverage ratio of 3.67 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, NARAE NANOTECH CORPORATION posted a return on equity (ROE) of 66.08, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.86 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 43.31, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 49.40, useful for judging operating efficiency across full business cycles. The company generates approximately 383.35M in revenue per employee across its workforce of 166.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.08 indicates how many times NARAE NANOTECH CORPORATION sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, NARAE NANOTECH CORPORATION recorded 16.57B in income tax expense. That works out to an effective tax rate of 20.22, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 81.94B, leaving 65.37B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, NARAE NANOTECH CORPORATION's stock has gained approximately 110.09% over the past 52 weeks. The 50-day moving average sits at 6,435.60, while the 200-day moving average is 5,321.75.

Over the twelve months ended June 30, 2026, NARAE NANOTECH CORPORATION generated 63.92B in revenue and converted that into 65.37B in net income, yielding earnings per share of 5,948.61. EBITDA reached 3.16B, while operating income came in at 3.16B.

As of June 30, 2026, NARAE NANOTECH CORPORATION holds 54.33B in cash and equivalents against 144.30M in total debt, resulting in a net debt position of -2.93B. Total book value stands at 129.77B, with working capital of 70.28B providing operational flexibility.

NARAE NANOTECH CORPORATION produced 13.88B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.61B in capital expenditures, free cash flow totaled 12.27B - equivalent to 1,116.28 per share.

Over the twelve months ended June 30, 2026, NARAE NANOTECH CORPORATION posted a gross margin of 26.05, reflecting its pricing power and cost economics. The operating margin of 4.95 and net profit margin of 102.27 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 19.25, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 112.15, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to NARAE NANOTECH CORPORATION shareholders.

As of June 30, 2026, NARAE NANOTECH CORPORATION has an Altman Z-Score of 3.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.